Harmony Biosciences Holdings, Inc.: AMERICAN CENTURY INVESTMENT MANAGEMENT INC discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
American Century Investment Management Inc. disclosed a stake exceeding 5% in Harmony Biosciences Holdings Inc. via a Schedule 13G filing with the SEC (accession 0000052388-26-000481). The passive-investment manager crossed the 5% beneficial-ownership threshold that triggers the disclosure requirement. The exact share count and percentage were not specified in the filing headline. The move signals growing institutional interest in the CNS-focused biopharma, whose shares trade under the ticker HRMY. Investors will watch for further 13G/13D amendments and quarterly 13F updates for changes in American Century's position.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
American Century Investment Management Inc, Harmony Biosciences Holdings, Inc.